These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9437539)

  • 21. Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis.
    Hasling C; Eriksen EF; Melkko J; Risteli L; Charles P; Mosekilde L; Risteli J
    J Bone Miner Res; 1991 Dec; 6(12):1295-300. PubMed ID: 1724340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta.
    Kauppila S; Tekay A; Risteli L; Koivisto M; Risteli J
    Eur J Clin Invest; 1998 Oct; 28(10):831-7. PubMed ID: 9792997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.
    Tähtelä R; Turpeinen M; Sorva R; Karonen SL
    Clin Biochem; 1997 Feb; 30(1):35-40. PubMed ID: 9056107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y; Ochi M; Tokue A
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement of PICP and PINP in the evaluation of pharmaceutical treatment efficacy for osteoporosis].
    Nakatsuka K; Nishizawa Y; Miura M
    Clin Calcium; 2006 Jun; 16(6):977-85. PubMed ID: 16751694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediators.
    Liu PY; Hoey KA; Mielke KL; Veldhuis JD; Khosla S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1953-60. PubMed ID: 15623811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal collagen turnover markers in intrauterine growth restriction.
    Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
    Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
    Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole.
    Kyvernitakis I; Knöll D; Struck M; Hars O; Bauer T; Hadji P
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):159-66. PubMed ID: 24292402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating matrix metalloproteinases and procollagen propeptides in inguinal hernia.
    Li J; Zhang X; Sun Q; Li W; Yu A; Fu H; Chen K
    Hernia; 2018 Jun; 22(3):541-547. PubMed ID: 29484522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical usefulness of blood PICP, PINP and ICTP concentrations as bone metastasis markers in prostate cancer patients].
    Kobayashi Y; Tokue A
    Nihon Rinsho; 1998 Aug; 56(8):2072-6. PubMed ID: 9750510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
    Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
    Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women.
    Komi J; Heikkinen J; Rutanen EM; Halonen K; Lammintausta R; Ylikorkala O
    Gynecol Endocrinol; 2004 Mar; 18(3):152-8. PubMed ID: 15255284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.